Trase Raises $107 Million Seed for Healthcare and Defense AI Agents

A 107 million dollar seed round is enormous for a company barely out of stealth, reflecting investor appetite for agentic AI that can survive the compliance and liability demands of hospitals and defense agencies rather than consumer apps. Trase's outcomes-based billing model, where it only gets paid when efficiency actually improves, is a notable break from typical SaaS pricing and a sign vendors are being forced to prove ROI upfront in risk-averse buyer categories. Landing both Duke Health and the U.S. Navy as customers this early suggests real traction beyond hype.